LOG IN
SIGN UP
News
LNSR
2.260
+2.26%
0.050
LENSAR Earnings Perspective: Return On Capital Employed
Benzinga · 6d ago
LENSAR (LNSR) Gets a Buy from BTIG
TipRanks · 03/16 14:45
BRIEF-Lensar Reports Fourth Quarter And Full Year 2022 Results And Provides Business Update
Reuters · 03/16 11:37
Earnings Scheduled For March 16, 2023
Benzinga · 03/16 10:59
-- Earnings Flash (LNSR) LENSAR Reports Q4 Revenue $10.2M, vs. Street Est of $10M
-- Earnings Flash (LNSR) LENSAR Reports Q4 Revenue $10.2M, vs. Street Est of $10M
MT Newswires · 03/16 07:16
BTIG Reaffirms Their Buy Rating on LENSAR (LNSR)
TipRanks · 02/22 10:35
Madison Avenue Partners Now Owns 6.10% of LENSAR (LNSR)
NASDAQ · 02/14 14:47
Silver Point Capital Now Owns 4.40% of LENSAR (LNSR)
NASDAQ · 02/14 14:45
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Fusion Pharmaceuticals (FUSN)
TipRanks · 02/14 14:10
BRIEF-Lensar Announces Preliminary Fourth Quarter And Full Year 2022 Results
Reuters · 02/14 12:44
LENSAR gives prelim Q4 and FY numbers
Seeking Alpha · 02/14 12:22
North Run Capital Increases Position in LENSAR (LNSR)
NASDAQ · 02/13 21:59
LENSAR to Present at Two Upcoming Investor Conferences
ORLANDO, Fla., November 22, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Execu...
Business Wire · 11/22/2022 13:00
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Benzinga · 11/22/2022 08:49
LENSAR GAAP EPS of -$0.39 beats by $0.23, revenue of $7.75M misses by $0.15M
Seekingalpha · 11/09/2022 13:40
LENSAR Q3 EPS $(0.39) Beats $(0.62) Estimate, Sales $7.75M Miss $7.90M Estimate
Benzinga · 11/09/2022 12:05
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
ORLANDO, Fla., November 09, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for th...
Business Wire · 11/09/2022 12:00
-- Earnings Flash (LNSR) LENSAR Posts Q3 Revenue $7.7M, vs. Street Est of $7.9M
-- Earnings Flash (LNSR) LENSAR Posts Q3 Revenue $7.7M, vs. Street Est of $7.9M
MT Newswires · 11/09/2022 07:10
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
ORLANDO, Fla., September 08, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced the application for cer...
Business Wire · 09/08/2022 11:00
LENSAR Applies for EU Certification of ALLY Adaptive Cataract Treatment System
LENSAR Applies for EU Certification of ALLY Adaptive Cataract Treatment System
MT Newswires · 09/08/2022 08:41
More
Webull provides a variety of real-time LNSR stock news. You can receive the latest news about Lensar Inc through multiple platforms. This information may help you make smarter investment decisions.
About LNSR
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It has developed the LENSAR Laser System to provide an alternative laser cataract treatment tool that allows the surgeon to better address astigmatism and improve visual outcomes. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The Company is also developing an integrated cataract treatment system, ALLY Adaptive Cataract Treatment System (ALLY). The ALLY system is designed to combine its existing femtosecond laser technology and a phacoemulsification system into a single unit that allows surgeons to perform each of the critical steps in a cataract procedure in a single operating room using this device.